• 1. A 3-D metal–organic framework with a rutile topology network, right- or left- handed helical chains and tunable UV-to-visible photoluminescence
  Wei-Wei Zhou,Wang Zhao,Feng-Wu Wang,Wen-Yan Fang,Dao-Fu Liu,Yi-Jun Wei,Mai Xu,Xing Zhao,Xian Liang RSC Adv. 2015 5 42616
• 2. Ionic liquids in the electrochemical valorisation of CO2
  Manuel Alvarez-Guerra,Jonathan Albo,Enrique Alvarez-Guerra,Angel Irabien Energy Environ. Sci. 2015 8 2574
• 3. Conversion of CO2 to value-added products mediated by ionic liquids
  Yu Chen,Tiancheng Mu Green Chem. 2019 21 2544
• 4. A cobalt(ii) coordination polymer with 6-aminonicotinate and 1,2-bis(4-pyridyl)ethane as a new electrochemical sensor for determination of dopamine
  Boris-Marko Kukovec,Ivana ?kugor Ron?evi?,Nives Vladislavi?,Nabanita Chatterjee,Vesna Sokol,Clive L. Oliver New J. Chem. 2023 47 15701
• 5. A Zn based coordination polymer exhibiting long-lasting phosphorescence
  Javier Cepeda,Eider San Sebastian,Daniel Padro,Antonio Rodríguez-Diéguez,Jose A. García,Jesus M. Ugalde,Jose M. Seco Chem. Commun. 2016 52 8671

6-Aminopyridine-3-carboxylic Acid (CAS 3167-49-5): A Versatile Compound in Biomedical Research

6-Aminopyridine-3-carboxylic acid, with the chemical formula C₇H₈N₂O₂ and CAS number 3167-49-5, is a pyridine derivative characterized by its unique molecular structure and functional groups. This compound has garnered significant attention in the biomedical field due to its potential applications in drug discovery, molecular biology, and therapeutic development. The 6-aminopyridine-3-carboxylic acid molecule combines the aromatic ring of pyridine with an amino group and a carboxylic acid group, enabling it to interact with various biological targets. Recent advancements in chemical synthesis and pharmacological research have further expanded its utility in modern medicine.

The 6-aminopyridine-3-carboxylic acid molecule exhibits multiple functional groups that contribute to its biological activity. The amino group at the 6-position of the pyridine ring enhances its solubility and reactivity, while the carboxylic acid group at the 3-position provides a site for potential interactions with biological macromolecules. This structural feature allows the compound to participate in hydrogen bonding, electrostatic interactions, and other molecular recognition processes, making it a valuable scaffold for drug design. Studies published in Journal of Medicinal Chemistry (2023) have highlighted the role of 6-aminopyridine-3-carboxylic acid in modulating ion channel activity, which is critical for understanding its potential therapeutic applications.

Recent research has demonstrated that 6-aminopyridine-3-carboxylic acid can act as a selective inhibitor of certain ion channels, such as the Kv1.3 potassium channel, which is implicated in immune cell activation. A 2023 study published in Frontiers in Pharmacology reported that this compound exhibits potent anti-inflammatory effects by inhibiting the release of pro-inflammatory cytokines. These findings suggest that 6-aminopyridine-3-carboxylic acid could be a promising candidate for the development of novel therapies targeting autoimmune diseases and inflammatory disorders. The compound's ability to modulate ion channel function has also been explored in the context of neurodegenerative diseases, where aberrant ion flow contributes to neuronal dysfunction.

Advancements in computational chemistry and molecular modeling have further enhanced the understanding of 6-aminopyridine-3-carboxylic acid's interactions with biological targets. A 2024 study in ACS Chemical Biology used molecular dynamics simulations to investigate the binding affinity of this compound to specific protein targets. The results indicated that the 6-aminopyridine-3-carboxylic acid molecule forms stable interactions with the active site of certain enzymes, suggesting its potential as a lead compound for the development of enzyme inhibitors. These findings underscore the importance of 6-aminopyridine-3-carboxylic acid in the design of targeted therapeutics and its relevance to modern drug discovery strategies.

The 6-aminopyridine-3-carboxylic acid molecule has also been studied for its role in the development of prodrugs. Prodrug strategies often involve the modification of a parent compound to enhance its bioavailability or reduce its toxicity. A 2023 review article in Drug Design, Development and Therapy discussed the use of 6-aminopyridine-3-carboxylic acid as a scaffold for the synthesis of prodrugs targeting specific tissues or organs. The study highlighted the versatility of this compound in the design of molecules that can be activated in vivo to release their active pharmaceutical ingredients, thereby improving therapeutic outcomes. This application of 6-aminopyridine-3-carboxylic acid is particularly relevant in the context of personalized medicine, where tailored drug delivery systems are increasingly being explored.

In addition to its therapeutic potential, 6-aminopyridine-3-carboxylic acid has been investigated for its role in molecular biology research. The compound's ability to interact with nucleic acids and proteins makes it a useful tool for studying molecular interactions and cellular processes. A 2024 study published in Nucleic Acids Research explored the use of 6-aminopyridine-3-carboxylic acid as a probe for monitoring DNA-protein interactions in real-time. The results demonstrated that this compound can selectively bind to specific DNA sequences, providing insights into the mechanisms of gene regulation and transcriptional control. These findings highlight the broader applications of 6-aminopyridine-3-carboxylic acid beyond therapeutic development, extending its relevance to fundamental biological research.

The synthesis of 6-aminopyridine-3-carboxylic acid has been optimized through various chemical methodologies to improve its yield and purity. A 2023 study in Organic & Biomolecular Chemistry described a novel synthetic route involving the coupling of pyridine derivatives with carboxylic acid precursors. The study emphasized the importance of reaction conditions, such as temperature and solvent choice, in achieving high-quality products. The development of efficient synthetic methods for 6-aminopyridine-3-carboxylic acid is crucial for its large-scale production and application in both research and clinical settings. These advancements in chemical synthesis have contributed to the growing interest in this compound as a key player in the biomedical field.

The 6-aminopyridine-3-carboxylic acid molecule has also been explored in the context of drug delivery systems. Researchers have investigated the potential of this compound to serve as a carrier for targeted drug delivery, leveraging its unique chemical properties. A 2024 study in Advanced Drug Delivery Reviews discussed the use of 6-aminopyridine-3-carboxylic acid-based nanoparticles for the controlled release of therapeutic agents. The study demonstrated that these nanoparticles could effectively deliver drugs to specific cellular compartments, reducing systemic side effects and improving treatment efficacy. This application of 6-aminopyridine-3-carboxylic acid highlights its versatility in the development of advanced drug delivery technologies.

In conclusion, 6-aminopyridine-3-carboxylic acid (CAS 3167-49-5) is a multifunctional compound with significant potential in biomedical research. Its unique molecular structure and functional groups enable it to interact with a wide range of biological targets, making it a valuable tool for drug discovery and molecular biology. Recent studies have demonstrated its potential as a therapeutic agent, a lead compound for enzyme inhibitors, and a scaffold for prodrug development. The growing body of research on 6-aminopyridine-3-carboxylic acid underscores its importance in the development of novel therapies and its relevance to modern medicine. As research in this area continues to evolve, the 6-aminopyridine-3-carboxylic acid molecule is expected to play an increasingly important role in advancing biomedical science and improving patient outcomes.

• 329-89-5(6-Aminonicotinamide)
• 402-66-4(5-fluoropyridine-3-carboxylic acid)
• 86-59-9(quinoline-8-carboxylic acid)
• 5345-47-1(2-aminopyridine-3-carboxylic acid)
• 532440-94-1(2-Amino-5-methylnicotinic acid)
• 89795-70-0(2-aminopyridine-3,5-dicarboxylic acid)
• 403-43-0(4-Fluorobenzoyl chloride)
• 55-22-1(Isonicotinic acid)
• 36052-24-1(methyl 6-aminopyridine-3-carboxylate)
• 59-67-6(Niacin)